Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Gene Therapy Clinical Trials 2016 NCI 4P30CA006516-51 6093 Vector MULLIGAN, RICHARD HARVARD MEDICAL SCHOOL MA $240,103
Gene Therapy Clinical Trials 2016 NCI 5P30CA008748-50 7556 Gene Transfer RIVIERE, ISABELLE SLOAN-KETTERING INST CAN RESEARCH NY $369,893
Gene Therapy Clinical Trials 2016 NCI 4R01CA077544-15 Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine DIAMOND, DON BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $539,228
Gene Therapy Clinical Trials 2016 NCI 4R01CA165206-05 CD19 Directed CAR Therapy JUNE, CARL UNIVERSITY OF PENNSYLVANIA PA $237,659
Gene Therapy Clinical Trials 2016 NICHD 5U01HD079066-02 Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis WOLFE, JOHN CHILDREN'S HOSP OF PHILADELPHIA PA $575,999
Gene Therapy Clinical Trials 2016 NCI 1P50CA192937-01A1 7612 Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients BRENTJENS, RENIER SLOAN-KETTERING INST CAN RESEARCH NY $313,752
Gene Therapy Clinical Trials 2016 NCI 4P01CA094237-14 7530 CHIMERIC T CELLS TARGETING NEUROBLASTOMA HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $295,508
Gene Therapy Clinical Trials 2016 NINDS 1R01NS094292-01 A Safety and Efficacy study of AAV2-hAADC for AADC deficiency BANKIEWICZ, KRYSTOF UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $967,730
Gene Therapy Clinical Trials 2016 NCI 5R01CA164333-04 TGFbeta Blockade in MART TCR-Engineered T Cell Melanoma Immunotherapy in Man KOYA, RICHARD ROSWELL PARK CANCER INSTITUTE CORP NY $352,335
Gene Therapy Clinical Trials 2016 NCI 1R01CA193140-01A1 Targeting the Ig-light chains with CAR-T cells in lymphoid tumors DOTTI, GIANPIETRO UNIV OF NORTH CAROLINA CHAPEL HILL NC $569,255
Gene Therapy Clinical Trials 2016 NIAID 1U01AI122260-01 A Phase II/III Clinical Trial of Gene Therapy for ADA-Deficient SCID KOHN, DONALD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $1,391,425
Gene Therapy Clinical Trials 2016 NIDDK 4R01DK095169-04 Gene Transfer for Galactosialidosis - Resub D'AZZO, ALESSANDRA ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $711,009
Gene Therapy Clinical Trials 2016 NCI 5R01CA186730-02 Efficient Delivery of Plasmid DNA to Achieve Appropriate Transgene Expression HELLER, RICHARD OLD DOMINION UNIVERSITY VA $367,893
Gene Therapy Clinical Trials 2016 NINDS 5R01NS064607-08 OV therapy induced changes in tumor secretome and their impact on therapy KAUR, BALVEEN OHIO STATE UNIVERSITY OH $336,875
Gene Therapy Clinical Trials 2016 NIAID 5U19AI117950-02 5400 A PHASE I STUDY OF C34-CXCR4 MODIFIED CD4 T CELLS IN HIV-1 INFECTED INDIVIDUALS TEBAS, PABLO UNIVERSITY OF PENNSYLVANIA PA $595,143
Gene Therapy Clinical Trials 2016 NCI 4K23CA154874-04 Optimization of adoptive immunotherapy with autologous CD20-specific T cells TILL, BRIAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,720
Gene Therapy Clinical Trials 2016 NCI 4P30CA006973-53 5841 CELL PROCESSING AND GENE THERAPY JAFFEE, ELIZABETH JOHNS HOPKINS UNIVERSITY MD $419,512
Gene Therapy Clinical Trials 2016 NEI 4R24EY022023-04 rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies HAUSWIRTH, WILLIAM UNIVERSITY OF FLORIDA FL $1,663,014
Gene Therapy Clinical Trials 2016 NCI 4P01CA023766-37 6334 Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to O'REILLY, RICHARD SLOAN-KETTERING INST CAN RESEARCH NY $433,106
Gene Therapy Clinical Trials 2016 NHLBI 4U10HL108945-06 Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT HESLOP, HELEN BAYLOR COLLEGE OF MEDICINE TX $160,218
Gene Therapy Clinical Trials 2016 NHLBI 1P01HL131471-01 7026 Clinical Trial and Immunologic aspects of muscle-directed rAAV1-AAT gene therapy FLOTTE, TERENCE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $502,500
Gene Therapy Clinical Trials 2016 NCI 4P01CA066726-19 5806 Preclinical Studies ALBELDA, STEVEN UNIVERSITY OF PENNSYLVANIA PA $352,395
Gene Therapy Clinical Trials 2016 NCI 4P01CA066726-19 5805 Clinical Trials in Mesothelioma STERMAN, DANIEL UNIVERSITY OF PENNSYLVANIA PA $302,808
Gene Therapy Clinical Trials 2016 NCI 4P01CA066726-19 5808 Administration ALBELDA, STEVEN UNIVERSITY OF PENNSYLVANIA PA $130,455
Gene Therapy Clinical Trials 2016 NCI 4P01CA066726-19 5809 Tissue Acquisition, Processing, and Pathology (TAPP) Core KALOS, MICHAEL UNIVERSITY OF PENNSYLVANIA PA $132,380
Gene Therapy Clinical Trials 2016 NCI 4P01CA066726-19 5810 Biostatistics & Data Management HEITJAN, DANIEL UNIVERSITY OF PENNSYLVANIA PA $97,246
Gene Therapy Clinical Trials 2016 NEI 5U10EY024247-03 Biostatistics Center for Leber's Hereditary Optic Neuropathy: Gene Therapy Trial FEUER, WILLIAM UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $116,387
Gene Therapy Clinical Trials 2016 NCI 1R01CA196975-01A1 First in-human PET imaging studies of NIS reporter [18F]BF4 DEGRADO, TIMOTHY MAYO CLINIC ROCHESTER MN $156,394
Gene Therapy Clinical Trials 2016 NCI 4P50CA121973-09 7390 Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory BUTTERFIELD, LISA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $406,288
Gene Therapy Clinical Trials 2016 NCI 2R01CA056821-22A1 Immunization Against Melanoma Differentiation Antigens WOLCHOK, JEDD SLOAN-KETTERING INST CAN RESEARCH NY $299,950
Gene Therapy Clinical Trials 2016 NCI 4K08CA169485-04 Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W CHAPUIS, AUDE FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,372
Gene Therapy Clinical Trials 2016 NHLBI 1R01HL122267-01A1 CF Gene Therapy with adeno-associated viral vectors CEBOTARU, LIUDMILA JOHNS HOPKINS UNIVERSITY MD $514,916
Gene Therapy Clinical Trials 2016 NEI 5U10EY023558-03 Leber's Hereditary Optic Neuropathy: Gene Therapy Clinical Trial GUY, JOHN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $1,367,380
Gene Therapy Clinical Trials 2016 NIAID 4U01AI100801-05 EFS-ADA Lentiviral Vector Transduction of Bone Marrow CD34+ Cells for ADA-SCID KOHN, DONALD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $592,671
Gene Therapy Clinical Trials 2016 NCI 4P50CA126752-10 0002 CHIMERIC T CELL ANTIGENS TARGETING IG KAPPA LIGHT CHAIN IN B CELL LYMPHOMA DOTTI, GIANPIETRO BAYLOR COLLEGE OF MEDICINE TX $220,316
Gene Therapy Clinical Trials 2016 NCI 4P50CA126752-10 9003 Cell and Vector Production GEE, ADRIAN BAYLOR COLLEGE OF MEDICINE TX $262,251
Gene Therapy Clinical Trials 2016 NCI 5R01CA175517-02 Efficacy of Dendritic Cell Vaccines Targeting CMV in Glioblastoma (phase 2 DC vaccine) MITCHELL, DUANE UNIVERSITY OF FLORIDA FL $616,384
Gene Therapy Clinical Trials 2016 NCI 4P50CA127001-09 7297 Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain Tumors FUEYO, JUAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $289,574
Gene Therapy Clinical Trials 2016 NCI 5P50CA058236-21 5602 Tissue-Specific Radiation Sensitization of Prostate Cancer by Aptamer-Targeted siRNA Knock-Down of DNA Repair Pattiway LUPOLD, SHAWN JOHNS HOPKINS UNIVERSITY MD $208,631
Gene Therapy Clinical Trials 2016 NCI 5R01CA136551-08 Targeted therapy of B cell malignances with CAR-T cells of defined composition RIDDELL, STANLEY FRED HUTCHINSON CANCER RESEARCH CENTER WA $560,424
Gene Therapy Clinical Trials 2016 NIAID 1U01AI125051-01 Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector PAI, SUNG-YUN CHILDREN'S HOSPITAL CORPORATION MA $1,132,346
Gene Therapy Clinical Trials 2016 NCI 1P50CA196510-01A1 8221 Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine GILLANDERS, WILLIAM WASHINGTON UNIVERSITY MO $489,305
Gene Therapy Clinical Trials 2016 NCATS 5U54NS065768-08 5625 Biomarkers for Disease Severity and Therapeutic Response in LINCL BALLON, DOUGLAS UNIVERSITY OF MINNESOTA MN $19,542
Gene Therapy Clinical Trials 2016 NIDDK 5U54NS065768-08 5625 Biomarkers for Disease Severity and Therapeutic Response in LINCL BALLON, DOUGLAS UNIVERSITY OF MINNESOTA MN $30,942
Gene Therapy Clinical Trials 2016 NINDS 5U54NS065768-08 5625 Biomarkers for Disease Severity and Therapeutic Response in LINCL BALLON, DOUGLAS UNIVERSITY OF MINNESOTA MN $22,293
Gene Therapy Clinical Trials 2016 NCATS 1U01TR001814-01 Disseminating Curative Biological Therapies for Rare Pediatric Diseases WILLIAMS, DAVID CHILDREN'S HOSPITAL CORPORATION MA $1,242,732
Gene Therapy Clinical Trials 2016 NCI 4P01CA148600-06 5308 GMP Cell Therapy and Vector Core GEE, ADRIAN UNIVERSITY OF TX MD ANDERSON CAN CTR TX $288,821
Gene Therapy Clinical Trials 2016 NCI 1ZIABC010985-09 Gene therapy of cancer ROSENBERG, STEVEN NIH $2,518,659
Gene Therapy Clinical Trials 2016 NCI 1ZIABC011479-04 T-cell receptor gene therapy for human papillomavirus-positive cancers HINRICHS, CHRISTIAN NIH $1,056,174
Gene Therapy Clinical Trials 2016 NCI 1ZIASC004020-39 Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS BERZOFSKY, JAY NIH $3,386,683
Gene Therapy Clinical Trials 2016 NIAID 1ZIAAI005047-14 Biodefense/Emerging Infection Vaccine Studies LEDGERWOOD, JULIE NIH $2,265,989
Gene Therapy Clinical Trials 2016 NIAID 1ZIAAI000991-10 Gene Therapy Clinical Trials for Chronic Granulomatous Disease KANG, ELIZABETH NIH $361,326
Gene Therapy Clinical Trials 2016 NIAID 1ZIAAI000992-10 Gene Therapy Clinical Trials for X-linked Severe Combined Immunodeficiency DE RAVIN, SUK NIH $361,326
Gene Therapy Clinical Trials 2016 NHLBI 1ZIAHL006172-04 Regenerative Therapies for Inherited Blood Disorders-Gene therapy LAROCHELLE, ANDRE NIH $391,476


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer